Advanced pancreatic cancer research hub
3 indexed studies · 0 currently recruiting
- authorisedTherapeutic exploratory (Phase II)
TAILOR-PANC: Molecularly Tailored Therapy versus Standard Care in Advanced Pancreatic Cancer (DPCG-02)
This study is looking at different individually tailored treatments for advanced pancreatic cancer. It aims to see if these personalised approaches can stop the cancer from growing for longer compared to standard care, and if they improve quality of life.
Denmark - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer (CheckVAC)
This study, called CheckVAC, is testing a new combination of medicines and a special vaccine for people with advanced pancreatic cancer. It's an early-stage study to see if the treatment is safe and how it works in the body.
Denmark - ongoing, recruitingHuman Pharmacology (Phase I)- Other
Study to Evaluate the Safety and Efficacy of Treatment with NLM-001 before Standard Chemotherapy plus Zalifrelimab in Patients with Advanced Pancreatic Cancer
This study is looking at a new treatment called NLM-001 for advanced pancreatic cancer. It combines NLM-001 with standard chemotherapy and another drug, Zalifrelimab, to see if it's safe and helps people better than current treatments. It's an early-stage study.
Spain